Digibind withdrawal and alternative availability

GlaxoSmithKline Pharmaceuticals will be discontinuing supply of Digibind from the 1st March 2011. This is an irrecoverable decision because the manufacturing site is closing and impacts on all Digibind markets.

An alternative product (Digifab) is available on a named patient basis from Beacon Pharmaceuticals Ltd. Digifab has been on the market in the US for several years.

Orders can be faxed to Beacon Pharmaceuticals (details below) or preferably sent by e-mail to

Stacey Sargant on stacey.sargant@beaconpharma.co.uk

Beacon Pharmaceuticals Ltd,

The Regent

The Broadway

Crowborough

East Sussex

TN6 1DA

Tel: 01892-600930

Fax: 01892-600937

Website: www.beaconpharma.co.uk

News posted on February 10, 2011

<< Back <<